These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19672301)

  • 1. In vitro and in vivo evidence that thrombospondin-1 (TSP-1) contributes to stirring- and shear-dependent activation of platelet-derived TGF-beta1.
    Ahamed J; Janczak CA; Wittkowski KM; Coller BS
    PLoS One; 2009 Aug; 4(8):e6608. PubMed ID: 19672301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of platelet-transforming growth factor beta-1 in the absence of thrombospondin-1.
    Abdelouahed M; Ludlow A; Brunner G; Lawler J
    J Biol Chem; 2000 Jun; 275(24):17933-6. PubMed ID: 10849431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor-beta1.
    Ahamed J; Burg N; Yoshinaga K; Janczak CA; Rifkin DB; Coller BS
    Blood; 2008 Nov; 112(9):3650-60. PubMed ID: 18544680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombospondin-1 is not the major activator of TGF-β1 in thrombopoietin-induced myelofibrosis.
    Evrard S; Bluteau O; Tulliez M; Rameau P; Gonin P; Zetterberg E; Palmblad J; Bonnefoy A; Villeval JL; Vainchenker W; Giraudier S; Wagner-Ballon O
    Blood; 2011 Jan; 117(1):246-9. PubMed ID: 20944070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between shear stress and platelet-derived transforming growth factor-β1 release and activation in animal models of aortic valve stenosis.
    Wang W; Vootukuri S; Meyer A; Ahamed J; Coller BS
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1924-32. PubMed ID: 24903096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombospondin 1 does not activate transforming growth factor beta1 in a chemically defined system or in smooth-muscle-cell cultures.
    Grainger DJ; Frow EK
    Biochem J; 2000 Aug; 350 Pt 1(Pt 1):291-8. PubMed ID: 10926856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latent TGF-beta1 activation by platelets.
    Blakytny R; Ludlow A; Martin GE; Ireland G; Lund LR; Ferguson MW; Brunner G
    J Cell Physiol; 2004 Apr; 199(1):67-76. PubMed ID: 14978736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the thiol isomerase-binding peptide, mastoparan, as a novel inhibitor of shear-induced transforming growth factor β1 (TGF-β1) activation.
    Brophy TM; Coller BS; Ahamed J
    J Biol Chem; 2013 Apr; 288(15):10628-39. PubMed ID: 23463512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombospondin-1 is a novel negative regulator of liver regeneration after partial hepatectomy through transforming growth factor-beta1 activation in mice.
    Hayashi H; Sakai K; Baba H; Sakai T
    Hepatology; 2012 May; 55(5):1562-73. PubMed ID: 22105716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A TSP-1 functional fragment inhibits activation of latent transforming growth factor-beta1 derived from rat alveolar macrophage after bleomycin treatment.
    Chen Y; Wang X; Weng D; Tao S; Lv L; Chen J
    Exp Toxicol Pathol; 2009 Jan; 61(1):67-73. PubMed ID: 18722097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombospondin-1 promotes hemostasis through modulation of cAMP signaling in blood platelets.
    Aburima A; Berger M; Spurgeon BEJ; Webb BA; Wraith KS; Febbraio M; Poole AW; Naseem KM
    Blood; 2021 Feb; 137(5):678-689. PubMed ID: 33538796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of thrombospondin-1-mediated TGF-β1 on collagen type III synthesis induced by high glucose.
    Tang M; Zhou F; Zhang W; Guo Z; Shang Y; Lu H; Lu R; Zhang Y; Chen Y; Zhong M
    Mol Cell Biochem; 2011 Jan; 346(1-2):49-56. PubMed ID: 20878350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluvastatin inhibits intimal hyperplasia in wild-type but not Thbs1-null mice.
    Desai P; Helkin A; Odugbesi A; Stein J; Bruch D; Lawler J; Maier KG; Gahtan V
    J Surg Res; 2017 Apr; 210():1-7. PubMed ID: 28457315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High glucose levels enhance TGF-beta1-thrombospondin-1 pathway in cultured human mesangial cells via mechanisms dependent on glucose-induced PKC activation.
    Tada H; Kuboki K; Nomura K; Inokuchi T
    J Diabetes Complications; 2001; 15(4):193-7. PubMed ID: 11457671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific interaction of oxidized low-density lipoprotein with thrombospondin-1 inhibits transforming growth factor-beta from its activation.
    Sakamoto Y; Miyazaki A; Tamagawa H; Wang GP; Horiuchi S
    Atherosclerosis; 2005 Nov; 183(1):85-93. PubMed ID: 15907858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of thrombospondin-1 ameliorates high glucose-induced peritoneal fibrosis through downregulation of TGF-β1/Smad3 signaling pathway.
    Jiang N; Zhang Z; Shao X; Jing R; Wang C; Fang W; Mou S; Ni Z
    J Cell Physiol; 2020 Jan; 235(1):364-379. PubMed ID: 31236971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paracrine up-regulation of monocyte cyclooxygenase-2 by platelets: role of transforming growth factor-beta1.
    Eligini S; Barbieri SS; Arenaz I; Tremoli E; Colli S
    Cardiovasc Res; 2007 May; 74(2):270-8. PubMed ID: 17250815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of transforming growth factor beta 1 in murine platelets reduces neointima formation without affecting arterial thrombosis.
    Schütz E; Bochenek ML; Riehl DR; Bosmann M; Münzel T; Konstantinides S; Schäfer K
    Thromb Haemost; 2017 Aug; 117(9):1782-1797. PubMed ID: 28726976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet TGF-β1 contributions to plasma TGF-β1, cardiac fibrosis, and systolic dysfunction in a mouse model of pressure overload.
    Meyer A; Wang W; Qu J; Croft L; Degen JL; Coller BS; Ahamed J
    Blood; 2012 Jan; 119(4):1064-74. PubMed ID: 22134166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36.
    Yehualaeshet T; O'Connor R; Green-Johnson J; Mai S; Silverstein R; Murphy-Ullrich JE; Khalil N
    Am J Pathol; 1999 Sep; 155(3):841-51. PubMed ID: 10487979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.